Page last updated: 2024-12-08
cubenol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
cubenol: from callus cultures of Chamomilla recutita (Asteraceae) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 519857 |
SCHEMBL ID | 14350491 |
MeSH ID | M0412836 |
Synonyms (10)
Synonym |
---|
1-isopropyl-4,7-dimethyl-1,3,4,5,6,8a-hexahydro-4a(2h)-naphthalenol |
cubenol |
1-epi-cubenol |
21284-22-0 |
epi-cubenol |
SCHEMBL14350491 |
COGPRPSWSKLKTF-UHFFFAOYSA-N |
10.beta.h-cadin-4-en-1-ol |
1-isopropyl-4,7-dimethyl-1,3,4,5,6,8a-hexahydro-4a(2h)-naphthalenol-, [1s-(1.alpha.,4.beta.,4a.beta.,8a.alpha.)]- |
DTXSID90880712 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 29.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (29.80) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (11.11%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |